Related Experiment Video

Updated: Mar 7, 2026

Intrastriatal Injection of Autologous Blood or Clostridial Collagenase as Murine Models of Intracerebral Hemorrhage
09:41

Intrastriatal Injection of Autologous Blood or Clostridial Collagenase as Murine Models of Intracerebral Hemorrhage

Published on: July 3, 2014

15.5K

Statins in conditions other than hypocholesterolemic effects for chronic subdural hematoma therapy, old drug, new

Hai Zou1, Xing-Xing Zhu2, Ya-Hui Ding1

  • 1Department of Cardiology, Zhejiang Provincial People's Hospital, Hangzhou, China.

Oncotarget
|February 9, 2017
PubMed

Insights

Statins may offer new hope for treating chronic subdural hematoma (CSDH). Research suggests statins can regulate angiogenesis and inflammation, potentially improving outcomes for CSDH patients at high risk of recurrence.

Area of Science:

  • Neurosurgery
  • Pharmacology
  • Medical Research

Background:

  • Chronic subdural hematoma (CSDH) is a prevalent intracranial hematoma globally.
  • Current treatments like burr-hole drainage have limitations, especially in elderly patients and those at high risk of recurrence.
  • Novel therapeutic strategies are needed for CSDH management.

Purpose of the Study:

  • To review current findings on statins' efficacy in treating CSDH.
  • To explore the potential mechanisms by which statins may benefit CSDH patients.
  • To identify statins as a potential new therapy for CSDH.

Main Methods:

  • Literature review of recent studies on statins and CSDH.
  • Analysis of statins' effects on angiogenesis and inflammation in the context of CSDH.
  • Synthesis of evidence regarding statin mechanisms in CSDH.

Main Results:

  • Statins have demonstrated potential benefits in managing CSDH.
  • Evidence suggests statins modulate angiogenesis and inflammation, key factors in CSDH.
  • These effects indicate a possible therapeutic role for statins in CSDH.

Conclusions:

  • Statins show promise as an adjunctive or alternative therapy for CSDH.
  • Understanding statin mechanisms could lead to improved CSDH treatment protocols.
  • Further research is warranted to confirm statins' role in CSDH management.

Keywords:
chronic subdural hematomaendothelial progenitor cellsinflammationstatinsvascular endothelial growth factor

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.6K
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
432
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
540
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.2K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.6K